#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemolytic uraemic syndrome Glomerulonephritis minimal lesion Autoinflammation with infantile enterocolitis Congenital generalised lipodystrophy Acquired haemophilia Congenital absence of bile ducts Demyelination Cardiac arrest Brain injury Glycogen storage disease type V Myelodysplastic syndrome with excess blasts Gastrointestinal stromal tumour Pulmonary alveolar haemorrhage Leukaemia Primary biliary cholangitis More trials…

    Learn about Rare Diseases

    Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Osteosarcoma recurrent – Treatment Krabbe’s disease – Life with Disease Hereditary hypophosphataemic rickets – Diagnostics Langerhans’ cell histiocytosis – Treatment Factor VIII deficiency – Life with Disease Metachromatic leukodystrophy – Basic Information Malignant fibrous histiocytoma – Life with Disease Mastocytosis – Treatment Wiskott-Aldrich syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SELTOREXANT Fremanezumab Rotigotine Hydrocortisone Hemisuccinate Dexamethasone Isonicotinate AMLENETUG Nefopam Fusidic Acid Retinol Palmitate BI-1607 Rizolipase XENON (133XE) BENZYLPENICILLIN PROCAINE L-SERINE Cannabis Sativa Flower Enpatoran Izaflortaucipir (18F) Tivozanib Pritelivir Encorafenib More therapies…

    Learn about Your Condition

    Anal cancer Pancreatitis relapsing Normal pressure hydrocephalus Diffuse large B-cell lymphoma Electronic cigarette user Phenylketonuria Left ventricular dysfunction Obesity Inclusion body myositis Tardive dyskinesia Hyperinsulinism Hairy cell leukaemia recurrent Haemorrhage intracranial Pancreatic carcinoma stage IV Cytokine release syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ischaemic stroke

  • Study of alteplase and tenecteplase for intravenous thrombolysis in patients with ischemic stroke who are taking direct oral anticoagulants

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    • Alteplase
    Austria Belgium Finland France Germany The Netherlands +3

  • Study of Cerebrolysin to improve arm function in patients recovering from ischemic stroke

    Recruiting

    3 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Cerebrolysin Concentrate
    • Sodium Chloride
    Romania

  • Study of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    • Atrial fibrillation
    Investigated Drugs:
    • Flecainide Acetate
    • Propafenone Hydrochloride
    • Amiodarone Hydrochloride
    Germany The Netherlands Spain

  • Study on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke

    Recruiting

    4 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • JX10
    Belgium Bulgaria Finland France Germany Greece +7

  • Study on Reducing Ischemic Stroke Damage with Low-Dose Human Albumin Solution and Sodium Chloride in Adult Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Human Albumin Solution
    • Sodium Chloride
    Czechia

  • Study on the Effectiveness of Tenecteplase in Patients with Acute Ischemic Stroke Taking Rivaroxaban, Apixaban, or Edoxaban

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Tenecteplase
    • Alteplase
    • Apixaban
    Denmark Norway Sweden
Previous Page
1 2 3 4 … 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!